Drugs / Ialuril
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03493997 | Apr 2017 → Oct 2018 | prostate cancer | Study Group for Urogenital Diseases, Italy | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ialuril | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03493997 ↗ |
| Route | Other | “intravesical Ialuril® weekly for 6 weeks” NCT03493997 ↗ |